A new once-a-day inhaler by the name of Relvar Ellipta will be available for asthma sufferers in Britain. The inhaler combines a daily dose of steroid, which is used to reduce inflammation in the airways, with a new type of long-lasting beta2 agonist, which focuses on dilation.
The product speaks to a need for simplicity, as studies show that many asthma patients find it difficult to manage two separate inhalers. The long-lasting drug will provide relief throughout the entire day, although some users may have to carry a blue inhaler for "immediate relief."
The drug is not limited to those with asthma however; it can also be used to combat a long list of respiratory illnesses, such as COPD.
Simplified Asthma Inhalers
More Stats +/-
In-Car Air Purifiers
Smart Asthmatic Gadgets
Cute Complete Puffer Kits
Allergen-Inhibiting Asthma Treatment
Revolutionary Asthma Vaccines